Author

G. A. Weiss

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Assay:proteomics· 2 Research Focus:protein design· 1 Assay:protein sequence· 1

Frequent Co-Authors

A. M. Santos· 2 shared B. M. Miller· 2 shared E. C. Sanders· 2 shared G. S. Salcedo· 2 shared H. M. Isoda· 2 shared J. L. Ricks-Oddie· 2 shared K. Bhuvan· 2 shared R. P. Dyer· 2 shared

Activity by Year

2020-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 41 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

A. M. Santos

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Evidence for Deleterious Antigenic Imprinting in SARS-CoV-2 Immune Response

S. R. Sen, E. C. Sanders, A. M. Santos, K. Bhuvan, D. Y. Tang, A. A. Gelston, B. M. Miller, J. L. Ricks-Oddie, G. A. Weiss

This study identifies cross-reactive antibodies against SARS-CoV-2 Ep9 epitope that originated from prior influenza infection, suggesting antigenic imprinting contributes to severe COVID-19 outcomes.

bioRxiv · May 21, 2021 · PreprintImmunology

Predicting COVID-19 Severity with a Specific Nucleocapsid Antibody plus Disease Risk Factor Score

S. Sen, E. C. Sanders, K. N. Gabriel, B. M. Miller, H. M. Isoda, G. S. Salcedo, J. E. Garrido, R. P. Dyer, R. Nakajima, A. Jain, A.-M. Caldaruse, A. M. Santos, K. Bhuvan, D. F. Tifrea, J. L. Ricks-Oddie, , G. A. Weiss

This paper identifies an antibody epitope and a risk score to predict severe COVID-19 outcomes with high specificity.

bioRxiv · Oct 15, 2020Immunology

Reengineering the Specificity of the Highly Selective Clostridium botulinum Protease via Directed Evolution

R. P. Dyer, H. M. Isoda, G. S. Salcedo, G. Speciale, M. H. Fletcher, L. Q. Le, Y. Liu, S. Z. Malik, E. J. Vazquez-Cintron, A. C. Chu, D. C. Rupp, B. Jacky, T. T. Nguyen, L. E. Steward, S. Majumdar, , G. A. Weiss

This study uses directed evolution to reengineer the BoNT/A protease to target SNAP23, improving its cleavage specificity and catalytic efficiency for therapeutic applications.

bioRxiv · Sep 29, 2020Biochemistry